CORRECTION article

Front. Bioeng. Biotechnol., 06 May 2025

Sec. Cell and Gene Therapy

Volume 13 - 2025 | https://doi.org/10.3389/fbioe.2025.1615190

Corrigendum: Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients

This article is a correction to:

  1. Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients

    1. Read original article
Jiyu Han,&#x;Jiyu Han1,2†Zitong Zhao&#x;Zitong Zhao2†Yanhong Wang,&#x;Yanhong Wang1,2†Tao Yu Tao Yu3*Daqian Wan, Daqian Wan1,2*
  • 1Department of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
  • 2Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration, Ministry of Education, Shanghai, China
  • 3Department of Orthopaedic, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

A Corrigendum on:
Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients

by Han J, Zhao Z, Wang Y, Yu T and Wan D (2022). Front. Bioeng. Biotechnol. 10:1052252. doi: 10.3389/fbioe.2022.1052252

In the published article, there was an error in affiliation [1]. Instead of “School of Medicine, Department of Orthopedics, Tongji Hospital, Tongji University, Shanghai, China”, it should be “Department of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China”.

In the published article, there was an error in the author list. The symbol † was erroneously included for authors Tao Yu and Daqian Wan. The corrected author list appears below.

“Jiyu Han1,2,†, Zitong Zhao2,†, Yanhong Wang1,2,†, Tao Yu3,* and Daqian Wan1,2,*”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: osteosarcoma, miR-449a, CCNB1, engineered exosomes, bioinformatics analysis, wet-lab experiment

Citation: Han J, Zhao Z, Wang Y, Yu T and Wan D (2025) Corrigendum: Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients. Front. Bioeng. Biotechnol. 13:1615190. doi: 10.3389/fbioe.2025.1615190

Received: 20 April 2025; Accepted: 22 April 2025;
Published: 06 May 2025.

Approved by:

Frontiers in Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Han, Zhao, Wang, Yu and Wan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tao Yu, eXQxMjQ4OEByamguY29tLmNu; Daqian Wan, d2Rxd2RxMTk4NkAxMjYuY29t

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.